Back to Journals » OncoTargets and Therapy » Volume 7

Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia

Total article views   Abstract views HTML views PDF downloads Totals
7,418 Dovepress* 5,201 1,446+ 1,390 6,647
PubMed Central* 0 771 365 771
Totals 5,201 2,217 1,755 7,418
*Since 26 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar